Horizon Oncology Center

1345 Unity Place, Suite 345 - Lafayette, IN 47905

For information about clinical trials being conducted in Lafayette, IN, please contact Linda Vaders at 765.446.5111.

Wael Harb, MD (Principal Investigator)

Trials at this Location:

Disease: Banking / Biorepository
A Biological Sample Collection Protocol of Patients with and without Metastatic Solid Organ Malignancies - BNK09-138
Status: Open to Accrual 10-06-2009; 27 of 200 accrued.
More Details

Disease: Breast
Predicting Response and Toxicity in Patients Receiving Chemotherapy for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative Study - DoD COE-01
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 09-27-2005 - 68 of 133 Patients Accrued
More Details

Disease: Breast
Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer: A Multicenter Genomic, Proteomic and Pharmacogenomic Correlative - DoD COE-03 (BRE-126)
Status: Open to Accrual at Limited Institutions Only - Open to Accrual 06-26-2009; 8 of 44 accrued.
More Details

Disease: Colorectal
A Phase I / Randomized Phase II Study of Second Line Therapy with Irinotecan and Cetuximab with or without RAD001 (an mTOR Inhibitor) for Patients with Metastatic Colorectal Cancer - GI05-102
Status: Suspended to Accrual to control accrual to cohort- Cohort2 has 1 slots remaining; Originally opened to Accrual 08-02-2007 - 18 of 119 Patients Accrued
More Details

Disease: Lung
A Randomized Double Blind Phase II Trial of Cisplatin plus Etoposide with/without Concurrent ZD6474 in Patients with Previously Untreated Extensive Stage Small Cell Lung Cancer - LUN06-113
Status: Open to Accrual - 01-23-2008 - 29 of 74 Patients Accrued
More Details

Disease: Lung
A Phase 1b/ 2 Study of AMG 479 in Combination with Paclitaxel and Carboplatin for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer - LUN08-137
Status: Open to Accrual; 9 patients accrued
More Details